NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Slaughter-Acey J, Behrens K, Claussen AM, et al. Social and Structural Determinants of Maternal Morbidity and Mortality: An Evidence Map [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2023 Dec. (Comparative Effectiveness Review, No. 264.)

Chapter 3Search Results

Our search identified 8,378 unique publications for screening. Based on inclusion criteria, we identified 118 eligible studies. We list all studies excluded at full text appraisal, by exclusion category, in Appendix B. Exclusions captured under “other reasons” are varied and overlapping, so often not easily placed into a more singular category. For example, an “other reasons” exclude might have been for both study quality and a challenging interpretation on whether the risk factors were interpersonal in nature. See Figure 3.1 for details of the screening process.

The 118 included studies were published between 2000 and 2022. The studies contained 221 specifically named exposures or factors of interest. While many of these exposures or factors of interest are comparable or overlap, studies used various language and operational definitions for them. Using the named exposures, we categorized the studies into 11 broad exposure domains based on the main social-structural determinant of health. Table 3.1 presents the number of included studies by Key Question and exposure domain. The exposure domains are illustrated by example named exposure or factor of interest. Some studies used data that focused on particular populations, such as Black, Hispanic, or military veterans. As shown in Table 3.1, these populations represent only a subset of the many potential populations of interest.

Table 3.2 presents the number of included studies by Key Qquestion, outcome domain, and special populations for those outcomes. The outcome domains are illustrated by examples of named outcome variables from included studies.

As shown in Table 3.3, included data varied widely in sample size and source. Sample sizes ranged from as small as 16 women whose deaths were examined for potential preventability, to several million pregnant or birthing people. Categories of data sources are provided in Table 3.3. Nine studies used Pregnancy Risk Assessment Monitoring System data.

Figures

Figure 3.1 is a flowchart of the results of the search and screening process for the review. The top row of the flow chart is titled "searching" and contains two boxes, on the left is "records identified through database searching (n=9444)" and on the right is "records identified through other sources (n=0)". A line connects these two boxes to arrow pointing below to the "screening" section containing a breakdown of the records which contains later stages in the screening process. At the top is "records after duplicates removed (n=8378)" with arrow pointing to the right to "duplicates (n=1066)", on the next row is "records after title/abstract screening (n=1622)" with arrow pointing to the right to "excluded at title/abstract (n=6756)." On the next row is "articles retrieved at full text (n=1622)" with arrow pointing to the right to "unretrievable full texts not found (n=0)". On the next row is "articles after full text screening (n=574)" with arrow pointing to the right to excluded full text with reasons (n=1048); exluded on: population (n=44), intervention/exposure (n=178), comparator (n=0), outcome (n=352), study design (n=152), non-US (n=11), publication type (n=84), other reasons (n-365), duplicates (n=14). There is an arrow pointdown from "articles after full text screening (n=574)" to the critical appraisal and synthesis section. There is box showing "articles included after critical full text appraisal (n=574)" with arrow pointing to the right to "excluded from appraisal with reasons (n=456); population (n=18), exposure (n=146), comparison (n=0), outcome (n=107), study design (n=86), timing (n=15), other (n=93), duplicates (n=5). At the bottom is a box stating "studies included in narrative synthesis (n=118)"

Figure 3.1Literature flow diagram

Abbreviations: n = number

Tables

Table 3.1Identified eligible studies by major exposure domain

Key Question, Number of StudiesExposure DomainSpecial Populations

KQ1 – 27 studies

KQ2 – 11 studies

Identity and Discrimination

Race or Ethnicity, Including Nativity, and Acculturation

Reported racial discrimination

Spatial polarization (segregation)

Rural/urban Socioeconomic factors

Disparities in care

Gender or sexual minority

Patterns of SDOH

Black

African American

White

Hispanic

Asian

Immigrants

2nd or 3rd generation immigration status

KQ1 – 9 studies

KQ2 – 3 studies

Socioeconomic status

Maternity leave

Household income

Public insurance

State income inequality

Unstable housing

Homelessness

Food insecurity (in combination)

Low-income

Homeless

KQ1 – 12 studies

Violence

Intimate Partner Violence

Domestic Violence

Latina

Low-income

Urban

KQ1 – 4 studies

Trauma

Childhood Trauma/ACEs

Lifetime trauma exposure

Reported racial discrimination

Military sexual trauma

African American

Veterans

KQ1 – 3 studies

Psychosocial Stress

Stressful life events

Partner-related stress

PTSD

None

KQ1 – 17 studies

KQ2 – 11 studies

Structural/Institutional

Obstetrical unit closure

Maternity care deserts

Payment policies

Neighborhood physical disorders

Food deserts

Incarceration

Municipal expenditures

Rural

Urban

Medicaid

KQ1 – 3 studies

KQ2 – 3 studies

Rural/Urban

Rural

Urban

KQ1 – 6 studies

Environmental

Green factors

Pollution

Heat exposure

Urban

KQ1 – 2 studies

KQ2 – 1 study

Comorbidities

Pre-existing psychopathy

Substance use

HIV

SARS-CoV-2

Women living with HIV
KQ2 – 4 studies

Hospital

Quality of care

Safety-net burden

Teaching affiliation

Rural

Medicaid

KQ1 – 1 study

KQ2 – 1 study

Healthcare Use

Access to healthcare

Late entry to prenatal care

Rural/Urban

Abbreviations: KQ=Key Question; N=number; ACEs=adverse childhood events; PTSD=post-traumatic stress disorder; SDOH=social determinants of health

Table 3.2Identified eligible studies by outcome domain

Key Question, Number of StudiesOutcome DomainSpecial Populations

KQ1 – 4

KQ2 - 5

Cost/Healthcare Use

Postpartum Emergency Department use

Postpartum readmission

Maternal Intensive Care Unit admission

Cost

Maternal hospital stay length

African American

Urban

Homeless

KQ1 - 37

KQ2 - 1

Depression

Postpartum depressive symptoms

Depressed mood

Depressive disorder

Black

White

Arabic descent Immigrants

Women living with HIV

US & foreign-born Latinas Veterans

Mexican descent

Women who worked during pregnancy

KQ1 - 7

KQ2 - 1

Diabetes

Gestational diabetes

Medicaid insured women

Hispanic

Non-Hispanic White

KQ1 - 18

KQ2 - 3

Hypertensive Disorders

Hypertension

Pregnancy-induced hypertension

Hypertensive disorders

Preeclampsia

Non-Hispanic Black women

Urban

Medicaid insured

KQ1 - 10

KQ2 - 6

Maternal Mortality

Pregnancy-related death

Preventable in-hospital mortality

In-hospital death

Black

White

Rural

Low-income

KQ1 - 10

Other Mental Health or Substance Use

PTSD

Suicidal ideation

Substance use

Anxiety

Stress

Latina

KQ1 - 23

KQ2 - 23

Severe Maternal Morbidity

Blood transfusion

Postpartum hemorrhage

Major laceration

Major puerperal infection

Obstetric complications

Black

African American

White

Indigenous

Somali immigrants

Sexual or gender minority

US military, active or veteran

Women experiencing loss of nearest obstetric unit

KQ1 - 4

Weathering *

Epstein-Barr virus reactivation

Chronic placental inflammation

Excess heart age

African American

Caucasian

White

KQ1 – 2

KQ2 - 1

Cardio/metabolic-Disorders

Peripartum cardiomyopathy

Cardiometabolic disorders

Low-income

African American

White

Hispanic

*

Weathering is the physiological effect of premature aging caused by chronic stressful experiences

Abbreviations: KQ=Key Question; N=number; ACEs=adverse childhood events; PTSD=post-traumatic stress disorder

Table 3.3Data sources, number of studies, and sample size ranges

Data Source CategoriesN StudiesSample Size Range
Clinic5115 – 498
Single Hospital11100 – 34,383
Hospital System516 – 675,553
Programs2556 – 10,038
City6191,947 – 591,455
State (4 PRAMS)33118 – 3,020,525
Multi-State (5 PRAMS)111,717 – 6,879,332
Regional2301 – 38,915
National (3 PRAMS)16501 – 138,311,788
Secondary analysis of Randomized Controlled Trial data5930 – 5,759

Abbreviations: PRAMS=Pregnancy Risk Assessment Monitoring System